About Spidia
SPIDIA is a 4-year project, funded by the European Union FP7 programme to the value of 9 million Euros, which brings together a consortium of 16 leading academic institutions, International organisations and life sciences companies.
The project is coordinated by QIAGEN GmbH and aims to tackle the standardisation and improvement of pre-analytical procedures for in-vitro diagnostics. The proposed research and standardisation activities cover all steps from creation of evidence-based guidelines to creation of tools for the pre-analytical phase to testing and optimisation of these tools through the development of novel assays and biomarkers.
SPIDIA RING TRIALS
In order to evaluate the current standardisation of the pre-analytical phase at the European level for DNA/RNA obtained from blood/plasma, we have planned 3 ring trials:
1) SPIDIA-DNA- evaluation of DNA quality/quantity from WHOLE BLOOD sample
2) SPIDIA-DNAplas – evaluation of DNA quality/quantity from WHOLE BLOOD sample plus the evaluation of DNA quality/quantity/integrity from PLASMA sample
3) SPIDIA-RNA – evaluation of RNA quality/quantity/stability from WHOLE BLOOD Sample
If you are interested to learn more and to join us, you can find all the requested information and the application form at the web site: www.efcclm.eu. and click on “SPIDIA”.
This work is supported by funding under the Seventh Research Framework Programme of the European Union, (FP7-HEALTH-2007-1.2.5). This website has been created in the context of the SPIDIA project. All information is provided "as is" and no guarantee or warranty is given that the information fits for any particular purpose. The user thereof uses the information at its sole risk and liability.
